Emgality Receives First FDA Approval for Treating Cluster Headache
Patients treated with Emgality had 8.7 fewer cluster headache attacks at 3.0 weeks versus 5.2 with placebo
Policy Changes Proposed to Meet Projected Need for Palliative Care
Modeling suggests the number of palliative care physicians is decreasing
Functional Limitations Persist One Year After Mild TBI
Fifty-three percent of patients with mild traumatic brain injury report functional limitations at 12 months
May 2019 Briefing – Neurology
Here are what the editors at HealthDay consider to be the most important developments in Neurology for May 2019. This roundup includes the latest...
Guidelines Issued for Addressing Heart Disease Risk in HIV
Individuals with HIV have significantly higher rates of CVD, may have underuse of statins, antithrombotics
FDA Takes Hard Look at CBD
CBD products have swamped the market due to change in federal law, not because of new medical evidence
ACP Issues Position on Response to Physician Impairment
Rehabilitated doctors should be reintegrated into practice as long as patient safety not compromised
Higher LDL-C Levels Linked to Early-Onset Alzheimer Disease
Cases with EOAD have higher levels of LDL-C, greater frequency of rare genetic coding variants of APOB
Lupus Manifestations Appear to Differ by Race, Ethnicity
Increased risk for severe manifestations seen among blacks, Hispanics, and Asians/Pacific Islanders
Recommendations Developed for Pediatric Multiple Sclerosis Trials
Biological rationale exists for using treatments proven efficacious in adults with MS for pediatric MS
